Skip to main content

Abbott, Promega Collaborate on RNA Sample Prep

NEW YORK, May 19 - Abbott Laboratories and Promega said today that they would collaborate on RNA extraction products for molecular diagnostics labs.


The companies will co-develop a system to purify and extract viral RNA from patient samples using Abbott's magnetic particle technology. The system will be manufactured by Promega and distributed by Abbott.


The RNA extraction system will be used in Abbott's m1000, an automated sample preparation system for molecular diagnostics that will be introduced later this year, Abbott said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.